Invitae has hired restructuring advisers as it explores strategic options, including a potential bankruptcy filing, the Wall Street Journal reported Monday, citing unnamed sources familiar with the matter. The genetic testing company could file for bankruptcy within weeks, according to the Journal report. Invitae is working to strengthen its balance sheet, and its board of directors formed a special committee focused on improving the company’s capital structure, a spokesperson told MedTech Dive on Tuesday, reiterating what the company disclosed in its third-quarter earnings release.
Read the full article: Invitae Hires Advisers, Considers Bankruptcy //
Source: https://www.medtechdive.com/news/invitae-advisers-bankruptcy-wsj/706764